Celano Michael 4
4 · Larimar Therapeutics, Inc. · Filed Jan 20, 2022
Insider Transaction Report
Form 4
Celano Michael
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-01-18+80,000→ 80,000 totalExercise: $8.75Exp: 2032-01-18→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]The option vests 25% on January 18, 2023, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.